Strata Skin Sciences today announced it signed an exclusive distribution agreement with Mino Labs to commercialize its products in Mexico.
Through the deal, Mino Labs will distribute Strata Skin Sciences’ TheraClear X, VTrac and XTrac in Mexico for three years.
“We are excited to have entered into an exclusive sales agreement with MINO Labs,” Strata Skin Sciences CEO Bob Moccia said in a news release. “With the addition of Mexico, Strata has the potential to access a nearly $300 million market for acne, psoriasis, and vitiligo. Mino’s 20 years of experience in the pharmaceutical industry and deep expertise in the Central and Latin American region, will allow Strata to provide those in Mexico who suffer from skin conditions another treatment option. In particular, there is a high need for acne treatments as 80%1 of the Mexican population is affected by low to severe acne. We look forward to continuing to broaden the reach of our treatment devices and help those who suffer from various skin conditions.”
Strata Skin Sciences is developing devices for the in-office treatment of various dermatologic conditions such as psoriasis, vitiligo and acne. The TheraClear X is an acne therapy system and the XTrac is an excimer laser. The VTrac is a lamp system for dermatologic conditions.
“We are excited for our partnership with Strata to bring their innovative dermatologic products to Mexico,” Mino Labs CEO Manuel Cosme Odabachian said. “Our company’s vision is to provide innovative healthcare solutions that assist companies to grow their commercial territories, acquisition of products, as well as services using our infrastructure and expertise. We are thrilled to begin offering Strata’s devices through our well-established sales channels and relationship and ultimately bring relief to those suffering from dermatologic conditions.”